$3.15
-0.13-3.96%
Last update: Nov 3, 3:49 PM
MiMedx Group Inc (MDXG) Stock Price, Quote, News & History
MDXGNASDAQ
U.S. stock futures rise, Meta shares drop 9.4%, Teladoc Health and Rentokil Initial fall after mixed financial results.
You can purchase shares of MiMedx Group (NASDAQ:MDXG) through any online brokerage.
Other companies in MiMedx Group’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
MiMedx Group has a consensus price target of $9.29.
The stock price for MiMedx Group (NASDAQ: MDXG) is $3.15 last updated November 3, 2026 at 3:49 PM EST.
There are no upcoming dividends for MiMedx Group.
MiMedx Group does not have any upcoming earnings scheduled.
There is no upcoming split for MiMedx Group.
MiMedx Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine,...
